Please enable JavaScript to continue using this application.

Compare $INMB vs $SER | Chartloom

Compare

$INMB vs $SER

INmune Bio Inc · Serina Therapeutics Inc

INMB

INmune Bio Inc

SER

Serina Therapeutics Inc

Compare $INMB vs $SER

Comparing INmune Bio Inc and Serina Therapeutics Inc

INMBINmune Bio Inc

SERSerina Therapeutics Inc

INMBINmune Bio Inc

Market cap

$50M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

22.7%

52W performance

-6.0%

FCF yield

-31.3%

SERSerina Therapeutics Inc

Market cap

$30M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-64.5%

FCF yield

-70.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INMB

SER

Detailed metrics comparison

INMB

INmune Bio Inc

SER

Serina Therapeutics Inc

Market Cap

INMB$50M

SER$30M

Enterprise Value

INMB$32M

SER$10M

Price

INMB$1.89

SER$2.00

P/E Ratio

INMBN/A

SERN/A

P/S Ratio

INMB1,071.30x

SER345.73x

EV/Sales

INMB703.08x

SER207.28x

EV/EBITDA

INMB0.00x

SER0.00x

P/B Ratio

INMB2.63x

SER2.66x

P/FCF Ratio

INMBN/A

SERN/A

EV/FCF

INMB-2.02x

SER-0.47x

PEG Ratio

INMBN/A

SERN/A

Forward P/E (NTM)

INMBN/A

SERN/A

Forward P/S (NTM)

INMBN/A

SERN/A

Revenue (TTM)

INMB$0

SER$0

Revenue Growth (YoY)

INMB-100.0%

SERN/A

Forward Rev Growth

INMB150.6%

SER0.0%

Gross Margin (TTM)

INMB0.0%

SER65.1%

Operating Margin (TTM)

INMB0.0%

SER0.0%

EBITDA Margin (TTM)

INMB0.0%

SER0.0%

Net Margin (TTM)

INMB0.0%

SER0.0%

FCF Margin (TTM)

INMBN/A

SERN/A

Net Income (TTM)

INMB$-18M

SER$-17M

FCF (TTM)

INMB$-16M

SER$-21M

EPS (TTM)

INMB-$0.69

SER-$1.03

ROE (TTM)

INMB-8287.0%

SER-10679.0%

ROA (TTM)

INMB-6223.0%

SER-9480.0%

ROIC (TTM)

INMB-8287.0%

SER-8268.0%

Cash

INMB$18M

SER$23M

Debt

INMB$0

SER$3M

Net Cash/Debt

INMB$18M

SER$20M

Current Ratio (TTM)

INMB4.04x

SER6.65x

Quick Ratio (TTM)

INMB3.94x

SER6.12x

Debt/Equity (TTM)

INMB0.00x

SER0.16x

Debt/Assets (TTM)

INMB0.0%

SER0.0%

Interest Coverage (TTM)

INMBN/A

SERN/A

Net Debt/EBITDA (TTM)

INMB0.00x

SER0.00x

Beta

INMB0.91

SER8.13

52W Performance

INMB-6.0%

SER-64.5%

YTD Performance

INMB22.7%

SER-3.8%

% from 52W High

INMB-27.3%

SER-65.0%

% from 52W Low

INMB73.4%

SER63.9%

Asset Turnover (TTM)

INMB0.00x

SER0.02x

FCF Yield (TTM)

INMB-31.3%

SER-70.7%

Earnings Yield (TTM)

INMB-36.6%

SER-56.2%

Dividend Yield (TTM)

INMBN/A

SERN/A

Rule of 40

INMB-100.0

SER0.0

EV/GP/RG

INMBN/A

SERN/A

Ticker research

View INMB research View SER research

Metric	INMB INmune Bio Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$50M	$30M
Enterprise Value	$32M	$10M
Price	$1.89	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	1,071.30x	345.73x
EV/Sales	703.08x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.63x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.02x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	150.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-17M
FCF (TTM)	$-16M	$-21M
EPS (TTM)	-$0.69	-$1.03
ROE (TTM)	-8287.0%	-10679.0%
ROA (TTM)	-6223.0%	-9480.0%
ROIC (TTM)	-8287.0%	-8268.0%
Financial Health
Cash	$18M	$23M
Debt	$0	$3M
Net Cash/Debt	$18M	$20M
Current Ratio (TTM)	4.04x	6.65x
Quick Ratio (TTM)	3.94x	6.12x
Debt/Equity (TTM)	0.00x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.91	8.13
52W Performance	-6.0%	-64.5%
YTD Performance	22.7%	-3.8%
% from 52W High	-27.3%	-65.0%
% from 52W Low	73.4%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-31.3%	-70.7%
Earnings Yield (TTM)	-36.6%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INMB research	View SER research

Valuation

P/S Ratio

SER

345.73x

INMB

1,071.30x

EV/FCF

INMB

-2.02x

SER

-0.47x

Growth & revenue

Revenue Growth TTM

INMB

-100.0%

Forward Revenue Growth

INMB

150.6%

SER

0.0%

Profitability & performance

Gross Margin

SER

65.1%

INMB

0.0%

ROE

INMB

-8287.0%

SER

-10679.0%

FCF Yield %

INMB

-31.3%

SER

-70.7%

52-Week Performance

INMB

-6.0%

SER

-64.5%

Detailed metrics comparison

INMB

INmune Bio Inc

SER

Serina Therapeutics Inc

Market Cap

INMB$50M

SER$30M

Enterprise Value

INMB$32M

SER$10M

Price

INMB$1.89

SER$2.00

P/E Ratio

INMBN/A

SERN/A

P/S Ratio

INMB1,071.30x

SER345.73x

EV/Sales

INMB703.08x

SER207.28x

EV/EBITDA

INMB0.00x

SER0.00x

P/B Ratio

INMB2.63x

SER2.66x

P/FCF Ratio

INMBN/A

SERN/A

EV/FCF

INMB-2.02x

SER-0.47x

PEG Ratio

INMBN/A

SERN/A

Forward P/E (NTM)

INMBN/A

SERN/A

Forward P/S (NTM)

INMBN/A

SERN/A

Revenue (TTM)

INMB$0

SER$0

Revenue Growth (YoY)

INMB-100.0%

SERN/A

Forward Rev Growth

INMB150.6%

SER0.0%

Gross Margin (TTM)

INMB0.0%

SER65.1%

Operating Margin (TTM)

INMB0.0%

SER0.0%

EBITDA Margin (TTM)

INMB0.0%

SER0.0%

Net Margin (TTM)

INMB0.0%

SER0.0%

FCF Margin (TTM)

INMBN/A

SERN/A

Net Income (TTM)

INMB$-18M

SER$-17M

FCF (TTM)

INMB$-16M

SER$-21M

EPS (TTM)

INMB-$0.69

SER-$1.03

ROE (TTM)

INMB-8287.0%

SER-10679.0%

ROA (TTM)

INMB-6223.0%

SER-9480.0%

ROIC (TTM)

INMB-8287.0%

SER-8268.0%

Cash

INMB$18M

SER$23M

Debt

INMB$0

SER$3M

Net Cash/Debt

INMB$18M

SER$20M

Current Ratio (TTM)

INMB4.04x

SER6.65x

Quick Ratio (TTM)

INMB3.94x

SER6.12x

Debt/Equity (TTM)

INMB0.00x

SER0.16x

Debt/Assets (TTM)

INMB0.0%

SER0.0%

Interest Coverage (TTM)

INMBN/A

SERN/A

Net Debt/EBITDA (TTM)

INMB0.00x

SER0.00x

Beta

INMB0.91

SER8.13

52W Performance

INMB-6.0%

SER-64.5%

YTD Performance

INMB22.7%

SER-3.8%

% from 52W High

INMB-27.3%

SER-65.0%

% from 52W Low

INMB73.4%

SER63.9%

Asset Turnover (TTM)

INMB0.00x

SER0.02x

FCF Yield (TTM)

INMB-31.3%

SER-70.7%

Earnings Yield (TTM)

INMB-36.6%

SER-56.2%

Dividend Yield (TTM)

INMBN/A

SERN/A

Rule of 40

INMB-100.0

SER0.0

EV/GP/RG

INMBN/A

SERN/A

Ticker research

View INMB research View SER research

Metric	INMB INmune Bio Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$50M	$30M
Enterprise Value	$32M	$10M
Price	$1.89	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	1,071.30x	345.73x
EV/Sales	703.08x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.63x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.02x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	150.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-17M
FCF (TTM)	$-16M	$-21M
EPS (TTM)	-$0.69	-$1.03
ROE (TTM)	-8287.0%	-10679.0%
ROA (TTM)	-6223.0%	-9480.0%
ROIC (TTM)	-8287.0%	-8268.0%
Financial Health
Cash	$18M	$23M
Debt	$0	$3M
Net Cash/Debt	$18M	$20M
Current Ratio (TTM)	4.04x	6.65x
Quick Ratio (TTM)	3.94x	6.12x
Debt/Equity (TTM)	0.00x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.91	8.13
52W Performance	-6.0%	-64.5%
YTD Performance	22.7%	-3.8%
% from 52W High	-27.3%	-65.0%
% from 52W Low	73.4%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-31.3%	-70.7%
Earnings Yield (TTM)	-36.6%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INMB research	View SER research